Mark Corbet MacRae Randall
Chief Executive Officer at Commander Asset Management (Middle East) Ltd.
Profile
Mr. Mark C.
Randall is Chief Executive Officer at Commander Asset Management (Middle East) Ltd.
and Commander Asset Management Ltd.
He and the team formed Commander Asset Management in 2002.
After leaving the Royal Navy, Mr. Randall joined the London office of Bank Sarasin in 1985 and during his 17 year tenure, he held multiple positions within the company.
In 1994, he became an Executive Director before assuming the position of Managing Director.
This role included managing and advising Institutional funds and being responsible for all international securities trading for the Bank Sarasin Group.
He was also founding Chairman of the Acorn Alternative Strategies Overseas Ltd, a Hedge Fund of Fund company which had assets under management in excess of Chf 500 million.
He has held and continues to hold Non-Executive Director roles in both private and publicly quoted companies.
Mark Corbet MacRae Randall active positions
| Companies | Position | Start |
|---|---|---|
| Commander Asset Management (Middle East) Ltd. | Chief Executive Officer | 2002-04-30 |
Commander Asset Management Ltd.
 Commander Asset Management Ltd. Investment ManagersFinance Commander Asset Management Ltd. (CommanderAM) is an alternative investment firm headquartered in London, UK. The firm was founded by Mark Randall, Timothy Tatham, and James Rolfe in 2002. CommanderAM provides bespoke solutions to institutional investors and other financial institutions to manage or advise segregated accounts, funds, and indexes. | Chief Executive Officer | 2001-12-31 |
Former positions of Mark Corbet MacRae Randall
| Companies | Position | End |
|---|---|---|
CASI Pharmaceuticals, Inc. /Old/
 CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Director/Board Member | 2013-04-03 |
| Sarasin International Securities Ltd. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
CASI Pharmaceuticals, Inc. /Old/
CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD. | Health Technology |
| Commander Asset Management (Middle East) Ltd. | |
| Sarasin International Securities Ltd. | Finance |
Commander Asset Management Ltd.
Commander Asset Management Ltd. Investment ManagersFinance Commander Asset Management Ltd. (CommanderAM) is an alternative investment firm headquartered in London, UK. The firm was founded by Mark Randall, Timothy Tatham, and James Rolfe in 2002. CommanderAM provides bespoke solutions to institutional investors and other financial institutions to manage or advise segregated accounts, funds, and indexes. | Finance |
- Stock Market
- Insiders
- Mark Corbet MacRae Randall
